Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 15, 2016
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromesJoão Vinagre, Joana Nabais, Jorge Pinheiro, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2021
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk managementAudrey Bellesoeur, Ithar Gataa, Anne Jouinot, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2024
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National SurveyNicolas Benech, Nadim Cassir, Laurent Alric, et al.
European Journal of Cancer Care|October 23, 2022
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysisJeremie Zerbit, Marie Kroemer, Basile Fuchs, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitorsLucia Parlati, Mehdi Sakka, Aurelia Retbi, et al.
Genes|February 25, 2023
Spotlight on hTERT Complex Regulation in Cutaneous T-Cell LymphomasJoana Ropio, Martina Prochazkova-Carlotti, Rui Batista, et al.
Cancers|August 26, 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)Marion Detroit, Mathis Collier, Nathanaël Beeker, et al.
Nature Communications|July 27, 2013
Frequency of TERT promoter mutations in human cancersJoão Vinagre, Ana Almeida, Helena Pópulo, et al.
International Journal of Cancer|February 26, 2016
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphismRui Batista, Adriana Cruvinel-Carloni, João Vinagre, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2014
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasMiguel Melo, Adriana Gaspar da Rocha, João Vinagre, et al.
Pageof 6